Table 3 Predictors of subsequent stroke event using Cox proportional hazards model.
Parameter | Univariate | Multivariate (Forward) | ||
|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Age | 1.036 (0.986–1.088) | 0.162 |  |  |
Male gender | 1.288 (0.459–3.614) | 0.631 |  |  |
Diabetes mellitus | 1.283 (0.422–3.898) | 0.661 |  |  |
Hypertension | 0.813 (0.315–2.098) | 0.669 |  |  |
CAD (%) | 2.038 (0.271–15.320) | 0.489 |  |  |
Stroke (%) | 1.920 (0.682–5.405) | 0.217 |  |  |
CHF (%) | 1.906 (0.551–6.572) | 0.309 |  |  |
SBP (mmHg) | 1.006 (0.981–1.031) | 0.638 |  |  |
DBP (mmHg) | 0.983 (0.940–1.027) | 0.436 |  |  |
Heart rate (min−1) | 0.996 (0.972–1.020) | 0.725 |  |  |
Body mass index (kg/m2) | 0.908 (0.803–1.028) | 0.126 |  |  |
Triglyceride (mg/dL) | 0.998 (0.992–1.005) | 0.667 |  |  |
Total cholesterol (mg/dL) | 0.992 (0.977–1.007) | 0.280 |  |  |
Medications | ||||
 ACEI and/or ARB use (%) | 1.002 (0.3956–2.538) | 0.997 |  |  |
 β–blocker use (%) | 0.788 (0.305–2.033) | 0.622 |  |  |
 CCB use (%) | 1.298 (0.462–3.641) | 0.621 |  |  |
 Diuretics use (%) | 1.115 (0.432–2.877) | 0.822 |  |  |
 Antiplatelet use (%) | 0.822 (0.324–2.085) | 0.680 |  |  |
 Anticoagulant use (%) | 1.623 (0.628–4.1934) | 0.318 |  |  |
Echocardiographic data | ||||
 LAVI (ml/m2) | 1.020 (1.000–1.039) | 0.047 |  |  |
 LVEDD (mm) | 0.993 (0.930–1.059) | 0.827 |  |  |
 LVESD (mm) | 0.986 (0.931–1.043) | 0.619 |  |  |
 LVMI (g/m2) | 1.011 (1.000–1.022) | 0.050 |  |  |
 LVEF (%) | 0.984 (0.953–1.015) | 0.305 |  |  |
 E (cm/s) | 1.000 (0.980–1.021) | 0.969 |  |  |
 EDT (ms) | 1.001 (0.992–1.011) | 0.818 |  |  |
 E’ (cm/s) | 0.786 (0.633–0.976) | 0.029 |  |  |
 E/E’ | 1.086 (1.006–1.174) | 0.036 |  |  |
 LA strain (%) | 0.841 (0.745–0.950) | 0.005 | 0.844 (0.745–0.955) | 0.007 |
 E/LA strain (m/s) | 1.187 (1.013–1.391) | 0.034 |  |  |
